期刊文献+

多元分析模板图在监测肝移植受者FK506治疗窗浓度中的应用 被引量:4

The Multianalysis Templet Chart for FK506 Therapeutic Window Concentration in Liver Transplant Recipients
下载PDF
导出
摘要 目的:应用多元分析模板图为临床肝移植受者监测他可莫司(代号FK506)理想治疗窗浓度提供方法。方法:用Excel软件建立标准品、质控品和患者样本的多元分析模板图,对微粒子酶免疫分析法(MEIA)测定的肝移植受者全血FK506血药浓度数据进行处理。结果:为11例肝移植受者检测FK506血药浓度178例次,术后3个月内在理想治疗窗浓度范围内者占44.6 %,异常标准曲线5条,质控值失控3次。结论:多元分析模板图操作简单,使用方便,是监测FK506治疗窗浓度的实用工具。 Objective:To give some information for FK506 ideal therapeutic window concentration in liver transplant recipients.Method:The multianalysis templet charts of calibrator,control and patents sample were developed through Excel soft,in order to handle the data of FK506 whole blood concentration determined via micro-particle enzyme immunoassay (MEIA).Results:The FK506 blood concentration were measured for 178 cases in 11 liver transplant recipients,and the ideal therapeutic window concentrations were accounted for 44.6% within three months after transplantation,along with 5 abnormal calibrator curve and 3 out of control.Conclusion:The multianalysis templet charts were simple,convenient and applied tool to carry out blood drug concentration monitoring.
出处 《微循环学杂志》 2010年第3期41-43,共3页 Chinese Journal of Microcirculation
关键词 治疗窗浓度 FK506 肝移植受者 多元分析 应用 监测 大环内酯类免疫抑制剂 板图 Multianalysis templet charts FK506 Liver transplant recipients Therapeutic window concentration MEIA
  • 相关文献

参考文献3

二级参考文献9

共引文献16

同被引文献32

  • 1周永恒,石磊,唐镜波.影响他克莫司血药浓度的因素[J].中国药房,2005,16(24):1909-1911. 被引量:15
  • 2Jusko WJ, Thomson AW, Fung J, et al. Consensus document:therapeutic monitoring of taerolimus (FK506)[J]. Ther Drog Morit, 1995,17(6) :606-614.
  • 3Undre NA, Stevenson P, Schiller A. Pharmacokinetics of tacroli mus: clinically relevant aspects [J]. Transplant Proc, 1999, 31 (7A) :S21-24.
  • 4National Committee for Clinical Laboratory Standards. EP10 A Preliminary evaluation of quantitative clinical laboratory methods [S]. Wayne PA, NCCLS, 1998.
  • 5Vinod PS, Kamal K M, Shrikant D, et al. Analytical methods vali dation bioavailability,bioequivalence and pharmacokinetic studies ~J~. Pharm Res,1992,9(4) :588-591.
  • 6Mesar I, Kes P, Hudolin T, et al. Rescue therapy with sirolimus in a renal transplant recipient with tacrolimus-induced hepatotoxicity [J]. Ren Fail, 2013, 35(10): 1434-1435.
  • 7Wu P, Ni X, Wang M, et al. Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients [J]. Ann Transplant, 2011, 16(1): 54-60.
  • 8Yah Y, Sun HH, Hunter DA, et al. Efficacy of short-term FK506 administration on accelerating nerve regeneration [J]. Neurorehabil Neural Repair, 2012, 26(6): 570-580.
  • 9叶伟民,陆慧琦,朱烨,李畅,韩焕兴.他克莫司在临床检测中的方法学比较[J].现代检验医学杂志,2008,23(2):85-87. 被引量:9
  • 10石炳毅,王振,郑慧丽,钱叶勇,韩孟霞.肾移植受者远期心脑血管疾病危险因素分析[J].中国医学科学院学报,2009,31(3):284-287. 被引量:10

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部